Anti-Estrogen Receptor beta (phospho S105) antibody (ab62257)

Publishing research using ab62257? Please let us know so that we can cite the reference in this datasheet.

ab62257 has been referenced in 2 publications.

  • Siegfried JM  et al. Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer. J Thorac Oncol 7:485-95 (2012). PubMed: 22258476
  • Hamilton-Burke W  et al. Phosphorylation of Estrogen Receptor {beta} at Serine 105 Is Associated with Good Prognosis in Breast Cancer. Am J Pathol 177:1079-86 (2010). WB, IHC-P ; Human . PubMed: 20696772

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up